RA Capital Nexus Fund II, L.P., Director, 10% Owner at Janux Therapeutics, Inc. (JANX), bought 990,016 shares at $12.46 ($12.3M) on 2023-07-19, disclosed to the SEC on 2023-07-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.46 | 495,008 | $6.2M | 50.0% |
| 2 | $12.46 | 495,008 | $6.2M | 50.0% |
| Total | $12.46 avg | 990,016 | $12.3M | 100% |
| Filing → |
| ANTX | BUY | 2023-08-22 | $16.0M | — | Filing → |
| DICE | BUY | 2023-03-30 | $29.6M | — | Filing → |
| ANTX | BUY | 2022-07-28 | $361K | — | Filing → |